Malignant Pancreatic Neoplasm — Trials

Malignant Pancreatic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,630 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 904
Recruiting: 503
Ph III recruiting: 45
Growth YoY: +18.8%
Industry share: 32%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.5%
Trials / 1,000 deaths: 18.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (516)

clinicaltrialsPublishedShowing 51–100 of 169 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03487016	First-line Therapy in Metastatic PDAC(FOOTPATH)	unknown	Phase 2	270	Ludwig-Maximilians - University of MunichOTHER	1	Sep 8, 2022	clinicaltrials
NCT04398446	Effect of Hemp-CBD on Patients With CIPN(Coala-T-CBD)	unknown	Phase 2	56	Main Line HealthOTHER	1	Sep 1, 2022	clinicaltrials